Impact of cumulative complications on 1-year treatment-related healthcare costs in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
Femke A van der ZantBob J L KooijmanJudith E K R HentzenWijnand HelfrichEmily M PloegRobert J van GinkelBarbara L van LeeuwenLukas B BeenJoost M KlaasePatrick H J HemmerChristian S van der HilstSchelto KruijffPublished in: BJS open (2022)
Treatment-related healthcare costs increase exponentially as more complications develop among patients who undergo CRS + HIPEC for the treatment of colorectal PMs. Anastomotic leakages after CRS + HIPEC lead to an increase of 295 per cent of treatment-related healthcare costs.